Fresenius Medical Care AG
Fresenius Medical Care provides dialysis services globally. The company offers treatment at outpatient clinics, supplies, patient support, and laboratory services. It also develops and distributes healthcare products like dialyzers, machines, and pharmaceuticals. Additionally, Fresenius provides renal medications, vascular services, and nephrology/cardiology services to patients. Products are sold directly or through local sales forces and distributors. The company was incorporated in 1996 and is headquartered in Germany.
Overview
Sector
Medical Care Facilities
Strengths
- Our discounted cash flow model points to 121% upside (target price 52.38 USD), and even our pessimistic growth scenario implies 79%: a margin of safety.
- Asset-light, cash-generative model: capital expenditure takes only 4.8% of revenue and free cash flow was positive in each of the last 8 years.
- Valued below its Medical Care Facilities peers: P/E 6.0x vs. a median of 23.1x, P/FCF 3.3x vs. a median of 11.5x and EV/EBITDA 3.2x vs. a median of 10.8x.
- Shareholder-friendly capital allocation: the share count has shrunk by 1.6% a year over the last three years through buybacks.
- Improving fundamentals over the last year: return on assets up 1.6 points, gross margin up 1.0 points and asset turnover up 9.9%.
- Cheaper than its own history: P/E 6.0x vs. a historical average of 8.8x and P/FCF 3.3x vs. a historical average of 5.4x.
Weaknesses
- Earnings are projected to decline (-10.0% per year).
Key Financial Data